FDA approves Vascepa to reduce cardiovascular risk in adults with elevated triglyceride levels Dec. 16, 2019
FDA grants accelerated approval to Vyondys 53 for DMD in patients amenable to skipping exon 53 Dec. 13, 2019
RSS